%D8%AA%D8%AF%D8%A7%D8%AE%D9%84_%D8%AF%D9%88%D8%A7%D8%A6%D9%8AL%C3%A9kov%C3%A9_interakceArzneimittelwechselwirkungDrug_interactionInteracci%C3%B3n_farmacol%C3%B3gicaElkarrekintza_farmakologikoL%C3%A4%C3%A4kkeiden_yhteisvaikutuksetInteraction_m%C3%A9dicamenteuse%E8%96%AC%E7%89%A9%E7%9B%B8%E4%BA%92%E4%BD%9C%E7%94%A8%EC%95%BD%EB%AC%BC_%EC%83%81%ED%98%B8%EC%9E%91%EC%9A%A9Wisselwerking_(medicijnen)Interaksjon_(legemiddel)Interakcja_farmakologicznaIntera%C3%A7%C3%A3o_medicamentosa%D0%92%D0%B7%D0%B0%D0%B8%D0%BC%D0%BE%D0%B4%D0%B5%D0%B9%D1%81%D1%82%D0%B2%D0%B8%D0%B5_%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2%D0%B5%D0%BD%D0%BD%D1%8B%D1%85_%D1%81%D1%80%D0%B5%D0%B4%D1%81%D1%82%D0%B2D%C3%A1lkasiid_vuorrov%C3%A1ikkuhusFarmakokineti%C4%8Dke_interakcijeMedsebojno_delovanje_zdravil%D0%A4%D0%B0%D1%80%D0%BC%D0%B0%D0%BA%D0%BE%D0%BA%D0%B8%D0%BD%D0%B5%D1%82%D0%B8%D1%87%D0%BA%D0%B5_%D0%B8%D0%BD%D1%82%D0%B5%D1%80%D0%B0%D0%BA%D1%86%D0%B8%D1%98%D0%B5T%C6%B0%C6%A1ng_t%C3%A1c_thu%E1%BB%91cQ718753%E8%8D%AF%E7%89%A9%E7%9B%B8%E4%BA%92%E4%BD%9C%E7%94%A8
about
P1542
High-priority drug–drug interactions for use in electronic health recordsThe SADI Personal Health Lens: A Web Browser-Based System for Identifying Personally Relevant Drug InteractionsA Study to Assess the Effect Tasimelteon on the Cytochrome P450 3A4 and 2C8 Enzymes in Healthy SubjectsDrug Interaction of Vildagliptin (LAF237) With Voglibose in Japanese Patients With Type 2 DiabetesPharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy SubjectsPharmacokinetic Interactions Between an Herbal Medicine (African Potato) and Antiretroviral Agents (Lopinavir/Ritonavir)Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy SubjectsDrug Interaction Between Ritonavir And SitaxsentanEffect Of Rifampin On Pharmacokinetics Of SitaxsentanA Drug Interaction Study With Fluticasone Furoate/GW642444 Inhalation Powder and KetoconazoleDrug Interaction Between Colchicine and Calcineurin Inhibitors in Renal Graft RecipientsEltrombopag/Boceprevir and Eltrombopag/Telaprevir Drug-Drug Interaction Study In Healthy Adult SubjectsDrug Interaction Study Between AZD3480 and WarfarinEffects of Combined Alcohol and Nitrous Oxide Intake - 15Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide - 3Study to Evaluate the Drug Interaction Between Dolutegravir (DTG) and Daclatasvir (DCV) in Healthy Adult SubjectsEffect of Dolutegravir on Metformin Pharmacokinetics in Healthy Adult SubjectsA Drug Interaction Study Between Bosutinib And Aprepitant In Healthy VolunteersRelative Bioavailability, Safety, Tolerability, Pharmacokinetics (PK) and Food Effect Study of GSK2140944 in Healthy SubjectsA Pharmacokinetics, Pharmacodynamics, and Safety Study of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK1322322 in Healthy Adult WomenA Phase 1 Study To Characterize The Safety, Tolerability, PK And PK Of Repeat Doses Of PF-06648671 In Healthy Adults And Healthy Elderly SubjectsEffect of Rifampin (RIF) on the Pharmacokinetics (PK) of Oral Cabotegravir (CAB) in Healthy SubjectsReduction in MACbar of Sevoflurane by Dexmedetomidine in ChildrenDrug-Drug Interaction Study to Evaluate the Pharmacokinetics and Safety of CTX 4430 and MidazolamEffects of PQ912 on the Pharmacokinetics of Midazolam and OmeprazoleThe Effects of Rifampin on the Pharmacokinetics of RosuvastatinDrug Interaction Study Between Bosutinib And DabigatranPharmacokinetic Interactions Between Telaprevir and Un-boosted AtazanavirPharmacokinetic of Everolimus and Atorvastatin Co-administrationEstimate the Effect of Telaprevir and Boceprevir on Maraviroc Pharmacokinetics in Healthy SubjectsAntiretroviral Drug Interaction Study in Volunteers With HIVVEG113971: An Open-Label Study of the Effects of Ketoconazole or Esomeprazole on Pazopanib PKAlcohol Interaction StudyDrug Interaction Between Paracetamol and WarfarinEffect Of Maraviroc On The Pharmacokinetics Of DigoxinA Study to Evaluate the Effect of Fimasartan on Pharmacokinetics, and the Safety of Digoxin in Healthy Male VolunteersSafety, Blood Levels, Drug Interaction and Effects of Repeated Doses of GSK1034702Effect of Antacids on the Pharmacokinetics of RaltegravirGSK1349572 Proton Pump Inhibitor Drug Interaction and Supratherapeutic Dose Study
P921
Q17505343-daf1d52b-4859-2df7-900d-c7d6423aa6bfQ28708988-0f214f1a-4f62-bfd3-a1d0-1b4e39d3dff9Q63807199-E07E4915-70CE-4FE8-B4A3-89B02BC099D8Q63813585-4EDFB768-FDDB-4E0D-BCFD-BD5D4BEE63BCQ63814189-BD47E7D6-777B-438F-8648-8A1833BBC36FQ63816719-6FE165E8-B115-44E5-AC18-2F7B4D1A4068Q63817859-470C1C6D-C9D5-4418-8F92-D039211788B1Q63818811-17B58E95-A4EA-4CFE-80D8-22A5CF6212F4Q63818813-3DF97E3C-8513-4203-AA63-6E1E2A5ADAC6Q63833132-2571C99D-5392-489B-A092-A7964A5CEDC0Q63834319-DEF1B628-FE2D-468C-AA34-F5376578435CQ63840808-BB4814C2-6411-4ACA-8D83-2AF5A8674514Q64045050-5DD08994-463D-4DB2-B050-8A09581BB226Q64139145-82D9D2FE-BE10-4AB9-909C-B5EF4AD04C8EQ64139146-BD3B232F-F02F-4DF1-8540-C4921D33B9E9Q64139157-DCB4BA23-EE09-4CCC-BF9A-EA89E5B51797Q64221673-A1A5FD3E-DB78-454E-A55A-6785DB76253DQ64223176-DA47E822-67EE-4E26-B309-05BFE2FE396FQ64335965-45BCF1CD-4395-4880-9593-0B1AA7EB2E1DQ64348547-B89E38AE-056E-43A5-8CCF-C971D4C947A0Q64353821-2A407023-B7D6-4C5B-B144-919524E16461Q64396877-186B2390-D61A-46A8-A4E6-AF1947F0A33CQ64396949-A2F57DBB-1526-4E24-A3C4-2924047ED311Q64601272-DC8619DF-8F06-4D4B-957C-26D17355ACFDQ64603437-8AEF2E78-6002-4EDA-ACA1-CAE012025B1FQ64607566-47A6F91F-F4C5-440C-967E-5139CF2644E2Q64611922-61582176-A123-4D98-9846-EA1AAD3FE9B9Q64612328-6A1A3A77-ED60-4E93-9DFB-9A69D38E7E1EQ64625280-43155D7F-D356-48FE-98E9-8F64167ED20AQ64636879-3FFAA9D3-CAA7-4E06-869A-27C8C9745D34Q64643565-C65D4903-17FC-45A2-B5D1-9AA744FFC240Q64647652-F5AF6D1D-55E4-490F-A98D-E2C52DC9C97BQ64652613-C711CC38-A722-4E50-AE9E-518BE9390175Q64654501-9BECF245-7334-4CF9-8F55-29843AB97E03Q64655917-6D7BFDAC-C8C2-418A-950A-B516285382C8Q64658108-59F302A1-2B49-4464-9FF3-960A228658C5Q64661362-BBC0EE4C-2471-4E60-B0C0-E0B9967CEB1CQ64664992-43B15302-B067-4885-B5DE-5DBE5442D791Q64665529-7BDDF1C0-C8FF-40AA-B83D-609F192DC46DQ64665691-99ECAE6C-1D4F-4D07-867F-22C4E4C1B6C3
P921
description
change in the action or side effects of a drug caused
@en
det at virkningen av ett legemiddel påvirkes av et annet legemiddel
@nb
lääkkeen aiheuttamat vaikutukset toisen lääkkeen tai muun aineen yhteydessä
@fi
reactie tussen combinaties van medicijnen
@nl
name
Arzneimittelwechselwirkung
@de
Dálkasiid vuorrováikkuhus
@se
Elkarrekintza farmakologiko
@eu
Farmakokinetičke interakcije
@sh
Interakcja farmakologiczna
@pl
Lääkkeiden yhteisvaikutukset
@fi
Lékové interakce
@cs
Medsebojno delovanje zdravil
@sl
Tương tác thuốc
@vi
drug interaction
@en
type
label
Arzneimittelwechselwirkung
@de
Dálkasiid vuorrováikkuhus
@se
Elkarrekintza farmakologiko
@eu
Farmakokinetičke interakcije
@sh
Interakcja farmakologiczna
@pl
Lääkkeiden yhteisvaikutukset
@fi
Lékové interakce
@cs
Medsebojno delovanje zdravil
@sl
Tương tác thuốc
@vi
drug interaction
@en
altLabel
Arzneimittelinteraktion
@de
Arzneimittelinteraktionen
@de
Interaccion farmacologica
@es
Interaccion farmacológica
@es
Interaccion medicamentosa
@es
Interacciones farmacologicas
@es
Interacciones farmacológicas
@es
Interacción medicamentosa
@es
Interacção medicamentosa
@pt
Interacções entre fármacos
@pt
prefLabel
Arzneimittelwechselwirkung
@de
Dálkasiid vuorrováikkuhus
@se
Elkarrekintza farmakologiko
@eu
Farmakokinetičke interakcije
@sh
Interakcja farmakologiczna
@pl
Lääkkeiden yhteisvaikutukset
@fi
Lékové interakce
@cs
Medsebojno delovanje zdravil
@sl
Tương tác thuốc
@vi
drug interaction
@en
P244
P349
P486
P6366
P646
P1417
topic/drug-interaction
P244
sh85039701
P349
P3827
drug-interactions